-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA'S LP-284 RECEIVES FDA ORPHAN DRUG DESIGNATION FOR SOFT TISSUE SARCOMAS

Reuters·01/20/2026 13:00:03

Please log in to view news